Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 968-973, May 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cappuccino, J. G.
Right arrow Articles by Tarnowski, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cappuccino, J. G.
Right arrow Articles by Tarnowski, G. S.

The Effect of Copper and Other Metal Ions on the Antitumor Activity of Pyruvaldehyde Bis(thiosemicarbazone)1

James G. Cappuccino, Stephen Banks, George Brown, Marilyn George and George S. Tarnowski

Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, and the Sloan-Kettering Division Graduate School of Medical Sciences, Cornell University, Medical College, New York, New York

Pyruvaldehyde bis(thiosemicarbazone) (PTS) was tested alone and in combination with dietary copper sulfate on 10 tumor systems. Potentiation of the cancerostatic activity of PTS by copper sulfate occurred in 8 of the tumor systems: Sarcoma 180, Taper liver tumor (solid and ascites), Carcinoma 1025, Sarcoma T241, Ridgway osteogenic sarcoma, Mecca lymphosarcoma, and Walker Rat Carcinosarcoma 256 (W256) as well as in the established 7-day-old W256 and 4-day-old Taper liver tumor (ascites). Copper ions appeared essential for activity of PTS in the treatment of the solid Taper liver tumor. In W256, calcium and zinc, in addition to copper, were able to enhance the antitumor activity of subinhibitory doses of the drug.

1 This study was supported by Contract No. SA-43-ph-2445 with The Cancer Chemotherapy National Service Center, National Cancer Institute, NIH, and in part by NCI Grant CA 08748.

Received 4/19/66. Accepted 1/ 9/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.